Metis Global Partners’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.09M | Sell |
5,756
-813
| -12% | -$436K | 0.08% | 216 |
|
|
2025
Q1 | $2.76M | Buy |
6,569
+695
| +12% | +$292K | 0.08% | 236 |
|
|
2024
Q4 | $2.43M | Buy |
5,874
+359
| +7% | +$148K | 0.07% | 233 |
|
|
2024
Q3 | $2.79M | Buy |
5,515
+171
| +3% | +$86.4K | 0.09% | 206 |
|
|
2024
Q2 | $2.6M | Buy |
5,344
+290
| +6% | +$141K | 0.09% | 192 |
|
|
2024
Q1 | $2.73M | Buy |
5,054
+45
| +0.9% | +$24.3K | 0.1% | 179 |
|
|
2023
Q4 | $2.78M | Sell |
5,009
-6
| -0.1% | -$3.33K | 0.11% | 165 |
|
|
2023
Q3 | $2.19M | Buy |
5,015
+1,072
| +27% | +$469K | 0.11% | 196 |
|
|
2023
Q2 | $1.98M | Buy |
3,943
+175
| +5% | +$87.9K | 0.11% | 197 |
|
|
2023
Q1 | $1.88M | Buy |
3,768
+740
| +24% | +$370K | 0.12% | 176 |
|
|
2022
Q4 | $1.24M | Buy |
3,028
+1,342
| +80% | +$547K | 0.11% | 211 |
|
|
2022
Q3 | $549K | Buy |
1,686
+208
| +14% | +$67.7K | 0.09% | 268 |
|
|
2022
Q2 | $519K | Buy |
1,478
+136
| +10% | +$47.8K | 0.08% | 279 |
|
|
2022
Q1 | $734K | Buy |
1,342
+599
| +81% | +$328K | 0.09% | 205 |
|
|
2021
Q4 | $489K | Buy |
+743
| New | +$489K | 0.14% | 168 |
|